| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | |
|---|
| Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | | FI | PI | | Azyter | 6 x 0.25 g | 6.52 | 16.30 | 10% | | Augentropfen: Azithromycinum Dihydricum 3.75 mg | THEA Pharma S.A. | A / SL | FB | G |
|
| | | FI | | | Aprokam | Durchstechflasche(n) | | | k.A. | | poudre pour solution injectable: Cefuroximum 50 mg | THEA Pharma S.A. | A | FB | G |
| | | FI | | | Aprokam | 10 Durchstechflasche(n) | | | k.A. | | poudre pour solution injectable: Cefuroximum 50 mg | THEA Pharma S.A. | A | FB | G |
| | | FI | | | Aprokam | 10 | | | k.A. | | poudre pour solution injectable: Cefuroximum 50 mg | THEA Pharma S.A. | A | FB | G |
|
| | | FI | PI | | AciVision 30 mg/g | 4.5 g | 9.69 | 26.95 | 10% | | Augensalbe: Aciclovirum 30 mg | OmniVision AG | A / SL | FB | G |
| | | FI | PI | | Virupos 30 mg/g | 4.5 g | 10.41 | 27.75 | 10% | | Augensalbe: Aciclovirum 30 mg | URSAPHARM Schweiz
GmbH | A / SL | FB | G |
| | | FI | | | Xorox 30 mg/g | 4.5 g | 10.30 | 27.60 | 10% | | Augensalbe: Aciclovirum 30 mg | AGEPHA PHARMA s.r.o.,
Bratislava,
Zweigniederlassung Zug | A / SL | FB | G |
|
| | | FI | PI | | Posiformin 2 % | 5 g | 4.66 | 9.45 | k.A. | | Augensalbe: Bibrocatholum 20 mg | URSAPHARM Schweiz
GmbH | B | FB | G |
|
| | | FI | PI | | Ciloxan | Tube(n) à 3.5 g | 4.78 | 14.45 | 10% | | Augensalbe: Ciprofloxacinum 3 mg | Novartis Pharma
Schweiz AG | A / SL | FB | G |
| | | FI | PI | | Ciloxan | 5 ml | 4.78 | 14.45 | 10% | | Augentropfen: Ciprofloxacinum 3 mg/ml | Novartis Pharma
Schweiz AG | A / SL | FB | G |
|
| | | FI | PI | | Dexafree UD 0,1% | 20 Einzeldosen | 4.37 | 14.00 | 10% | | Augentropfen: Dexamethasoni Natrii Phosphas 1.093 mg/ml | THEA Pharma S.A. | A / SL | FB | G |
| | | FI | PI | | Maxidex | 5 ml | 3.41 | 12.95 | 10% | | Augentropfen: Dexamethasonum 1 mg | Novartis Pharma
Schweiz AG | ● A / SL | FB | G |
| | | FI | PI | | Spersadex mono 0.1% | 5 ml | 4.26 | 13.85 | 10% | | Augentropfen: Dexamethasoni Natrii Phosphas 1 mg/ml | OmniVision AG | A / SL | FB | G |
| L | | FI | | | Ozurdex | Stück | 951.69 | 1051.45 | 10% | | intravitreales Implantat in Applikator: Dexamethasonum 700 µg | AbbVie AG | A / SL | FB | G |
| | | | | | Dexocol 1 mg/ml | 6 ml | | | k.A. | | collyre en solution: Dexamethasoni Dihydrogenophosphas 1 mg/ml | Horus Pharma Suisse SA | A | FB | G |
| | | | | | Dexocol 1 mg/ml | 3 x 6 ml | | | k.A. | | collyre en solution: Dexamethasoni Dihydrogenophosphas 1 mg/ml | Horus Pharma Suisse SA | A | FB | G |
|
| | | FI | PI | | Yellox | 5 ml | 5.88 | 15.65 | 10% | | Augentropfen: Bromfenacum | Bausch & Lomb Swiss AG | B / SL | FB | G |
|
| | | FI | PI | | Iopidine 0,5 % | 5 ml | 14.42 | 32.10 | 10% | | Augentropfen: Apraclonidinum 5 mg/ml | Essential Pharma
Switzerland GmbH | ● B / SL | FB | G |
| | | FI | PI | | Iopidine 1% | 2 Einzeldosen | 7.22 | 17.10 | 10% | | Augentropfen (Monodosen): Apraclonidinum 10 mg/ml | Essential Pharma
Switzerland GmbH | B / SL | FB | G |
| L | | FI | PI | | Iopidine 1% | 24 | 68.44 | 90.85 | 10% | | Augentropfen (Monodosen): Apraclonidinum 10 mg/ml | Essential Pharma
Switzerland GmbH | B / SL | FB | G |
|
| | | FI | PI | | Alphagan | 5 ml | 7.92 | 17.85 | 10% | | Augentropfen: Brimonidini Tartras 2 mg/ml | AbbVie AG | B / SL / SO | FB | G |
| | | FI | PI | | Alphagan | 3 x 5 ml | 20.24 | 38.45 | 10% | | Augentropfen: Brimonidini Tartras 2 mg/ml | AbbVie AG | B / SL / SO | FB | G |
| | | FI | PI | | Brimo-Vision 2 mg/ml | 60 x 0.35 ml | 7.35 | 17.25 | 10% | | Augentropfen Lösung im Einzeldosisbehältnis: Brimonidini Tartras 2 mg/ml | OmniVision AG | ● B / SL / SG | FB | G |
| | | FI | PI | | Brimo-Vision 2 mg/ml | 180 x 0.35 ml | 17.20 | 35.10 | 10% | | Augentropfen Lösung im Einzeldosisbehältnis: Brimonidini Tartras 2 mg/ml | OmniVision AG | B / SL / SG | FB | G |
|
| | | FI | | | Miostat | 12 1 Ampulle(n) à 1.5 ml | | | k.A. | | Injektionslösung: Carbacholum | Alcon Switzerland SA | ● B | FB | G |
|
| | | FI | PI | | Miochol E | 2 ml | | | k.A. | | Injektionslösung: Acetylcholini Chloridum 20 mg | Bausch & Lomb Swiss AG | B | FB | G |
|
| | | FI | PI | | Diamox | 500 mg | 12.36 | 29.85 | 10% | | Trockensubstanz: Acetazolamidum 500 mg | Advanz Pharma
Specialty Medicine
Switzerland GmbH | B / SL | FB | G |
| | | FI | PI | | Diamox - T | 25 Tablette(n) | 6.05 | 15.80 | 10% | | Tabletten: Acetazolamidum 250 mg | Advanz Pharma
Specialty Medicine
Switzerland GmbH | B / SL | FB | G |
| | | FI | PI | | Glaupax - T | 40 Tablette(n) | 7.61 | 17.50 | 10% | | Tabletten: Acetazolamidum 250 mg | OmniVision AG | B / SL | FB | G |
| | | FI | PI | | Glaupax - T | 100 Tablette(n) | 19.02 | 37.10 | 10% | | Tabletten: Acetazolamidum 250 mg | OmniVision AG | B / SL | FB | G |
| | | FI | PI | | Diamox Sustets | 30 Kapsel(n) | 25.89 | 46.85 | k.A. | | Kapseln: Acetazolamidum 500 mg | Corden Pharma
Fribourg SA | B | FB | G |
|
| | | FI | PI | | Azopt | 5 ml | 8.96 | 26.15 | 10% | | | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Azopt | 3 x 5 ml | 22.86 | 41.30 | 10% | | | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | | | | Brinzo-Vision 10 mg/ml | 5 ml | | | k.A. | | Augentropfensuspension: Brinzolamidum 10 mg/ml | OmniVision AG | B | FB | G |
| | | | | | Brinzo-Vision 10 mg/ml | 3 x 5 ml | | | k.A. | | Augentropfensuspension: Brinzolamidum 10 mg/ml | OmniVision AG | B | FB | G |
|
| | | FI | PI | | Simbrinza, Brinzolamid
10mg/ml | 5 ml | 15.32 | 33.10 | 10% | | Brimonidintartrat: 2 Wirkstoffe | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Simbrinza, Brinzolamid
10mg/ml | 3 x 5 ml | 43.64 | 63.90 | 10% | | Brimonidintartrat: 2 Wirkstoffe | Novartis Pharma
Schweiz AG | B / SL | FB | G |
|
| | | FI | PI | | Betoptic-S | 5 ml | 4.51 | 14.15 | 10% | | Augentropfen: Betaxololum 2.5 mg/ml | Medius AG | B / SL | FB | G |
| | | FI | PI | | Betoptic-S | 3 x 5 ml | 11.50 | 28.90 | 10% | | Augentropfen: Betaxololum 2.5 mg/ml | Medius AG | B / SL | FB | G |
| | | FI | PI | | Betoptic-S Single Dose | 60 Stück | | 60.00 | k.A. | | | Medius AG | B | FB | G |
|
| | | FI | PI | | Arteoptic LA 2 % | 3 ml | 4.57 | 14.20 | 10% | | Augentropfen: Carteololi Hydrochloridum 20 mg/ml | Bausch & Lomb Swiss AG | ● B / SL | FB | G |
| | | FI | PI | | Arteoptic LA 2% UD | 30 1 Einzeldosen à 0.2 ml | 6.74 | 16.55 | 10% | | Augentropfen: Carteololi Hydrochloridum 20 mg/ml | Bausch & Lomb Swiss AG | B / SL | FB | G |
| | | FI | PI | | Arteoptic LA 2 % | 3 x 3 ml | 11.70 | 29.15 | 10% | | Augentropfen: Carteololi Hydrochloridum 20 mg/ml | Bausch & Lomb Swiss AG | ● B / SL | FB | G |
| | | FI | PI | | Arteoptic 0,5 %,
Augentropfen | 5 ml | 6.60 | 15.80 | 10% | | Carteololi Hydrochloridum 20 mg | Bausch & Lomb Swiss AG | B / SL | FB | G |
| | | FI | PI | | Arteoptic 0,5 %,
Augentropfen | 3 x 5 ml | 16.84 | 35.75 | k.A. | | Carteololi Hydrochloridum 20 mg | Bausch & Lomb Swiss AG | B | FB | G |
|
| | | FI | PI | | Elymbus 0.1 mg/g | 30 x 0.3 g | 15.87 | 33.70 | 10% | | | THEA Pharma S.A. | B / SL | FB | G |
| | | FI | PI | | Elymbus 0.1 mg/g | 90 x 0.3 g | 45.23 | 65.60 | 10% | | | THEA Pharma S.A. | B / SL | FB | G |
| | | FI | PI | | Lumigan, 0.1 mg/ml | 3 ml | 14.66 | 32.35 | 10% | | Augentropfen: Bimatoprostum | AbbVie AG | B / SL | FB | G |
| | | FI | PI | | Lumigan, 0.1 mg/ml | 3 x 3 ml | 41.16 | 61.20 | 10% | | Augentropfen: Bimatoprostum | AbbVie AG | B / SL | FB | G |
| | | FI | PI | | Lumigan 0,3 mg/ml Unit
Dose | 30 x 0.4 ml | 17.82 | 35.80 | 10% | | Augentropfen: Bimatoprostum | AbbVie AG | B / SL | FB | G |
| | | FI | PI | | Lumigan 0,3 mg/ml Unit
Dose | 90 x 0.4 ml | 50.80 | 71.65 | 10% | | Augentropfen: Bimatoprostum | AbbVie AG | B / SL | FB | G |
| | | FI | PI | | Bimatoprost Labatec 0.3
mg/ml | | | | k.A. | | collyre en solution: Bimatoprostum | Labatec Pharma SA | | FB | G |
|
| | | FI | PI | | Atropine 0,5 % SDU Faure | 4 x 5 Einzeldosen | | 31.35 | k.A. | | Augentropfen: Atropini Sulfas 5 mg/ml | THEA Pharma S.A. | ● B | FB | G |
| | | | | | Ryjunea 0.1 mg/ml | 2.5 ml | | | k.A. | | collyre en solution: Atropini Sulfas | Santen SA | B | FB | G |
| | | | | | Ryjunea 0.1 mg/ml | 3 x 2.5 ml | | | k.A. | | collyre en solution: Atropini Sulfas | Santen SA | B | FB | G |
| | | FI | PI | | Skiatropin 0 | 4 ml | 2.85 | 6.85 | k.A. | | Augentropfen: Atropini Sulfas 3 mg | Chauvin Novopharma AG | B | FB | G |
|
| | | FI | | | Cyclogyl 0,5 % | 10 ml | | 25.30 | k.A. | | Augentropfen: Cyclopentolati Hydrochloridum 5 mg/ml | Alcon Switzerland SA | B | FB | G |
| | | FI | | | Cyclogyl 1 % | 10 ml | | 25.30 | k.A. | | Augentropfen: Cyclopentolati Hydrochloridum 10 mg/ml | Alcon Switzerland SA | B | FB | G |
|
| | KFI | FI | PI | | Relestat | 5 ml | 7.15 | 17.00 | 10% | | Augentropfen: Epinastini Hydrochloridum | AbbVie AG | B / SL | FB | G |
|
| | | FI | PI | | Allergo-COMOD | 10 ml | 6.00 | 11.10 | 10% | | Augentropfen: Natrii Cromoglicas 20 mg/ml | URSAPHARM Schweiz
GmbH | D / SL / SG | FB | G |
| | | FI | PI | | Opticrom-Allergo | 20 x 0.3 ml | | | k.A. | | Augentropfen in Ampullen: Natrii Cromoglicas 20 mg/ml | Spirig HealthCare AG | D | FB | G |
| | | FI | PI | | Opticrom-Allergo | 40 x 0.3 ml | | | k.A. | | Augentropfen in Ampullen: Natrii Cromoglicas 20 mg/ml | Spirig HealthCare AG | D | FB | G |
|
| | | FI | PI | | Allergodil | 6 ml | 5.99 | 15.75 | 10% | | Augentropfen: Azelastini Hydrochloridum | VERFORA SA | B / SL | FB | G |
| | | FI | PI | | Allergodil saisonal | 4 ml | | | k.A. | | Augentropfen: Azelastini Hydrochloridum | VERFORA SA | D | FB | G |
|
| | | FI | PI | | BILAXIN Ophta 6 mg / ml | 5 ml | | | k.A. | | Augentropfen: Bilastinum 6 mg/ml | A. Menarini GmbH | D | FB | G |
|
| | | FI | | | VISICLOR 30 mg/g | 0.8 g | | | k.A. | | | Sintetica SA | B | FB | G |
| | | FI | | | VISICLOR 30 mg/g | 10 x 0.8 g | | | k.A. | | | Sintetica SA | B | FB | G |
| | | FI | | | VISICLOR 30 mg/g | 20 x 0.8 g | | | k.A. | | | Sintetica SA | B | FB | G |
| | | FI | | | VISICLOR 30 mg/g | 50 x 0.8 g | | | k.A. | | | Sintetica SA | B | FB | G |
|
| L | | FI | | | Eylea, 2 mg/0,05 ml | Durchstechflasche(n) | 500.00 | 563.25 | 10% | | Injektionslösung: Afliberceptum 2mg / 0.05ml | Bayer (Schweiz) AG | B / SL / SO | FB | G |
| L | | FI | | | Eylea 2 mg/0.05 ml | | 500.00 | 563.25 | 10% | | Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl | Bayer (Schweiz) AG | B / SL / SO | FB | G |
| L | | FI | | | Mynzepli 40 mg/ml | | 417.33 | 478.45 | 10% | | Injektionslösung: Afliberceptum 2mg / 0.05ml | Advanz Pharma
Specialty Medicine
Switzerland GmbH | B / SL / SG | FB | G |
| L | | FI | | | Pavblu 40 mg/ml | | 417.33 | 478.45 | 10% | | Injektionslösung: Afliberceptum 2mg / 0.05ml | Amgen Switzerland AG | B / SL / SG | FB | G |
| L | | FI | | | Afqlir 40 mg/ml | | 417.33 | 478.45 | 10% | | Injektionslösung in Fertigspritze: Afliberceptum 2mg / 50µl | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | | | | Ahzantive 2 mg/0.05 ml | | 417.33 | 478.45 | 10% | | Injektionslösung in Fertigspritze: Afliberceptum 2mg / 0.05ml | Medvisis Switzerland AG | B / SL / SG | FB | G |
| L | | FI | | | Mynzepli 40 mg/ml | | 417.33 | 478.45 | 10% | | Injektionslösung in Fertigspritze: Afliberceptum 2mg / 0.05ml | Advanz Pharma
Specialty Medicine
Switzerland GmbH | B / SL / SG | FB | G |
| L | | FI | | | Pavblu 40 mg/ml | | 417.33 | 478.45 | 10% | | Injektionslösung in Fertigspritze: Afliberceptum 2mg / 0.05ml | Amgen Switzerland AG | B / SL / SG | FB | G |
| L | | FI | | | Eylea 8 mg/0.07 ml | | 500.00 | 560.20 | 10% | | Injektionslösung: Afliberceptum 8mg / 0.07ml | Bayer (Schweiz) AG | B / SL | FB | G |
| L | | FI | | | Eylea 8 mg/0.07ml | | 500.00 | 560.20 | 10% | | Injektionslösung in Fertigspritze: Afliberceptum 8mg / 0.07ml | Bayer (Schweiz) AG | B / SL | FB | G |
| | | FI | | | Aflivis 40 mg/ml | | 417.33 | 478.45 | k.A. | | Injektionslösung: Afliberceptum 2mg / 50µl | OmniVision AG | B | FB | G |
| | | FI | | | Afqlir 40 mg/ml | | | | k.A. | | Injektionslösung: Afliberceptum 2mg / 0.05ml | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Yesafili 40 mg/ml | | | | k.A. | | Injektionslösung: Afliberceptum 2mg / 0.05ml | Medius AG | B | FB | G |
| | | FI | | | Aflivis 40 mg/ml | | 417.33 | 478.45 | k.A. | | Injektionslösung in Fertigspritze: Afliberceptum 2mg / 50µl | OmniVision AG | B | FB | G |
| | | | | | Baiama 40 mg/ml | | | | k.A. | | Injektionslösung: Afliberceptum 2mg / 0.05ml | Horus Pharma Suisse SA | B | FB | G |
| | | | | | Eydenzelt 40 mg / ml | | | | k.A. | | Injektionslösung: Afliberceptum 2mg / 0.05ml | iQone Healthcare
Switzerland SA | B | FB | G |
| | | FI | | | Eylea 2 mg/0.05 ml | Spritze(n) | 913.48 | 1063.35 | k.A. | | Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl | Bayer (Schweiz) AG | B | FB | G |
| | | | | | Eydenzelt 40mg / ml | | | | k.A. | | solution injectable en seringue préremplie: Afliberceptum 2mg / 0.05ml | iQone Healthcare
Switzerland SA | B | FB | G |
|
| L | | FI | | | Beovu 120mg/ml | | 652.91 | 726.50 | 10% | | Injektionslösung in Fertigspritze: Brolucizumabum 120 mg/ml | Novartis Pharma
Schweiz AG | B / SL | FB | G |
|
| | | FI | PI | | Sérum autologue ICH 50% | 8 ml | | | k.A. | | Augentropfen: Serum Humanum Autologum 4 ml | Institut Central des
Hôpitaux Hôpital du
Valais Site Sion | B | FB | G |
|
| | | FI | PI | | Oxervate | 7 | | | k.A. | | Augentropfen: Cenegerminum | Dompé International SA | B | FB | G |
|
| | | | PI | H | Similasan Entzündete
Augen, Augentropfen 10 ml | 10 ml | | | k.A. | | 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | G |
| | | | PI | H | Mucokehl D5 | 5 ml | | | k.A. | | Augentropfen: Mucor Racemosus e Volumine Cellulae (Lyophil., Steril.) D5 Aquos (Hab 5B) | ebi-pharm ag | D | FB | G |
| | | | PI | H | Similasan Allergisch
reagierende Augen | 10 ml | | | k.A. | | Augentropfen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | G |
| | | | PI | H | Similasan Trockene Augen | 10 ml | | | k.A. | | Augentropfen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | G |
| | | | PI | | Similasan Überanstrengte
Augen N | 20 | | | k.A. | | Augentropfen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | G |
| | | | PI | | Similasan Allergisch
reagierende Augen N | 20 x 0.4 ml | | | k.A. | | Augentropfen Monodosen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | G |
| | | | PI | | Similasan Entzündete
Augen N | 20 x 0.4 ml | | | k.A. | | Augentropfen Monodosen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | G |
| | | | PI | | Similasan Trockene Augen N | 20 x 0.4 ml | | | k.A. | | Augentropfen Monodosen: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | G |
| | | | PI | H | Similasan Überanstrengte
Augen, Augentropfen 10 ml | 10 ml | | | k.A. | | Lösung: 3 Wirkstoffe | T&S Eye Care
Management AG | D | FB | G |
| | | | PI | H | Oculoheel | 20 x 0.45 ml | | | k.A. | | Augentropfen Monodosen: 4 Wirkstoffe | ebi-pharm ag | D | FB | G |
